Cargando…

Precision Nutrition for Alzheimer’s Prevention in ApoE4 Carriers

The ApoE4 allele is the most well-studied genetic risk factor for Alzheimer’s disease, a condition that is increasing in prevalence and remains without a cure. Precision nutrition targeting metabolic pathways altered by ApoE4 provides a tool for the potential prevention of disease. However, no long-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Norwitz, Nicholas G., Saif, Nabeel, Ariza, Ingrid Estrada, Isaacson, Richard S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073598/ https://www.ncbi.nlm.nih.gov/pubmed/33921683 http://dx.doi.org/10.3390/nu13041362

Ejemplares similares

Sex, ApoE4 and Alzheimer’s disease: rethinking drug discovery in the era of precision medicine
por: Paranjpe, Manish D., et al.
Publicado: (2021)

Preventative medicine and Alzheimer’s disease: is Alzheimer’s disease risk reduction achievable?
por: Sinyor, Benjamin, et al.
Publicado: (2021)

ApoE2 and Alzheimer's disease: time to take a closer look
por: Wu, Long, et al.
Publicado: (2016)

mTOR: Alzheimer's disease prevention for APOE4 carriers
por: Lin, Ai-Ling, et al.
Publicado: (2016)

Detrimental Effects of ApoE ε4 on Blood–Brain Barrier Integrity and Their Potential Implications on the Pathogenesis of Alzheimer’s Disease
por: Kirchner, Kevin, et al.
Publicado: (2023)

APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer’s Disease
por: Waring, Jeffrey F., et al.
Publicado: (2015)

Vascular Dysfunction Is Central to Alzheimer’s Disease Pathogenesis in APOE e4 Carriers
por: McCorkindale, Andrew N., et al.
Publicado: (2022)

Precision Medicine for Alzheimer’s Disease Prevention
por: Berkowitz, Cara L., et al.
Publicado: (2018)

Oscillatory hyperactivity and hyperconnectivity in young APOE-ɛ4 carriers and hypoconnectivity in Alzheimer’s disease
por: Koelewijn, Loes, et al.
Publicado: (2019)

APOE targeting strategy in Alzheimer’s disease: lessons learned from protective variants
por: Bu, Guojun
Publicado: (2022)

Perspective: Metabotyping—A Potential Personalized Nutrition Strategy for Precision Prevention of Cardiometabolic Disease
por: Palmnäs, Marie, et al.
Publicado: (2020)

Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers
por: Tao, Qiushan, et al.
Publicado: (2018)

A Systems View of the Differences between APOE ε4 Carriers and Non-carriers in Alzheimer’s Disease
por: Jiang, Shan, et al.
Publicado: (2016)

Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy
por: Cuyàs, Elisabet, et al.
Publicado: (2020)

Bioenergetic and inflammatory systemic phenotypes in Alzheimer’s disease APOE ε4‐carriers
por: Wilkins, Heather M., et al.
Publicado: (2021)

Precision medicine: Clarity for the clinical and biological complexity of Alzheimer’s and Parkinson’s diseases
por: Montine, Thomas J., et al.
Publicado: (2015)

APOE4 expression is associated with impaired autophagy and mitophagy in astrocytes
por: Eran, Schmukler, et al.
Publicado: (2021)

Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers
por: Edlund, Anna K., et al.
Publicado: (2021)

Vascular hypothesis of Alzheimer’s disease: role of apoE and apoE receptors
por: Bu, Guojun, et al.
Publicado: (2013)

The PSEN1, p.E318G Variant Increases the Risk of Alzheimer's Disease in APOE-ε4 Carriers
por: Benitez, Bruno A., et al.
Publicado: (2013)

APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease
por: Hou, Min, et al.
Publicado: (2021)

Increased hippocampal activation in ApoE-4 carriers and non-carriers with amnestic mild cognitive impairment
por: Tran, Tammy T., et al.
Publicado: (2016)

Commentary: Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk
por: Dzianok, Patrycja, et al.
Publicado: (2020)

Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients
por: Wilkins, Heather M., et al.
Publicado: (2017)

The pathway to secondary prevention of Alzheimer's disease
por: McDade, Eric, et al.
Publicado: (2020)

Effectiveness of online education for recruitment to an Alzheimer's disease prevention clinical trial
por: Saif, Nabeel, et al.
Publicado: (2020)

Cancer prevention and screening: the next step in the era of precision medicine
por: Loomans-Kropp, Holli A., et al.
Publicado: (2019)

A precision environmental health approach to prevention of human disease
por: Baccarelli, Andrea, et al.
Publicado: (2023)

Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's disease
por: Kim, Young Won, et al.
Publicado: (2020)

Memory precision of object-location binding is unimpaired in APOE ε4-carriers with spatial navigation deficits
por: Gellersen, Helena M, et al.
Publicado: (2021)

Amyloid deposition and ApoE4 carriers in idiopathic normal pressure hydrocephalus
por: Bundo, Masahiko, et al.
Publicado: (2015)

Insufficient evidence for vitamin E in Alzheimer's disease
por: Hermann, Dirk M.
Publicado: (2016)

ApoE4: an emerging therapeutic target for Alzheimer’s disease
por: Safieh, Mirna, et al.
Publicado: (2019)

Stem cell-derived three-dimensional (organoid) models of Alzheimer’s disease: a precision medicine approach
por: Kim, Sujung Jun, et al.
Publicado: (2021)

Outreach, Screening, and Randomization of APOE ε4 Carriers into an Alzheimer’s Prevention Trial: A global Perspective from the API Generation Program
por: Walsh, T., et al.
Publicado: (2023)

Finding effective combinations of compounds to prevent Alzheimer’s disease
por: Dhakal, Sudip, et al.
Publicado: (2022)

Precision Dosing: An Industry Perspective
por: Peck, Richard W.
Publicado: (2020)

Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer’s disease
por: Xian, Xunde, et al.
Publicado: (2018)

Reduced Hippocampal Volume in Healthy Young ApoE4 Carriers: An MRI Study
por: O'Dwyer, Laurence, et al.
Publicado: (2012)

Structural brain volume differences between cognitively intact ApoE4 carriers and non-carriers across the lifespan
por: Piers, Ryan J.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rrnc3f9t1n9gc9ooep2m607p19